NivolumabDrug ineffective: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1900卷 / 1期

关键词：

D O I：

10.1007/s40278-022-12607-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：255 / 255

相关论文

共 50 条

[1] Ipilimumab/nivolumabDrug ineffective and off-label use: case report
Reactions Weekly, 2022, 1898 (1) : 232 - 232
[2] Dacarbazine/nivolumabDrug eruption and nausea: case report
Reactions Weekly, 2019, 1751 (1) : 120 - 120
[3] Ipilimumab/nivolumabDrug induced interstitial pneumonia: case report
Reactions Weekly, 2022, 1911 (1) : 248 - 248
[4] NivolumabDrug-induced liver injury: case report
Reactions Weekly, 2019, 1761 (1) : 273 - 273
[5] NivolumabDrug-induced interstitial nephritis: case report
Reactions Weekly, 2024, 2033 (1) : 221 - 221
[6] Ipilimumab/NivolumabDrug induced diaphragmatic myopathy: case report
Reactions Weekly, 2024, 2037 (1) : 217 - 217
[7] Ipilimumab/nivolumabDrug-induced liver injury: case report
Reactions Weekly, 2019, 1753 (1) : 203 - 203
[8] Ipilimumab/nivolumabDrug-induced hypersensitivity syndrome: case report
Reactions Weekly, 2022, 1920 (1) : 266 - 266
[9] NivolumabDrug resistance following off-label therapy: case report
Reactions Weekly, 2020, 1808 (1) : 228 - 228
[10] SorafenibDrug ineffective: case report
Reactions Weekly, 2022, 1930 (1) : 497 - 497

← 1 2 3 4 5 →